Search results
Found 1070 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
General Research
3 November 2021
Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
Oxford to work with Brazil to establish clinical research hub
General Research
2 November 2021
The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.
PTSD in healthcare workers during pandemic could be exacerbated by past trauma
Coronavirus COVID-19 General Research
29 October 2021
While some of the high rates of post-traumatic stress (PTSD) seen in healthcare workers during the pandemic are specifically COVID-19-related, a more significant number of cases were linked to trauma that occurred earlier in their lives, researchers at the University of Oxford have found.
Oxford researchers test potential treatment for fatigue in long COVID patients
Clinical Trials Coronavirus COVID-19 General Research
29 October 2021
Radcliffe Department of Medicine researcher Dr Betty Raman is leading a new phase 2a clinical trial to investigate whether a drug could treat the fatigue and muscle weakness experienced by many patients who have recovered from COVID. The drug, AXA1125, is developed by the US-based biotechnology company Axcella Therapeutics.
Major new research network to investigate the body clock and stroke
General Research
29 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body’s internal clock and the disordered physiological processes associated with stroke.
Wearing face coverings protected wearers from COVID-19 infection – large scale study
Coronavirus COVID-19 General Research
28 October 2021
People who wore face coverings or masks outside of the home, and were more exposed to infection due to their circumstances, had ‘significantly’ lower rates of COVID-19 infection, according to research published in BMJ Open today, led by Oxford’s Leverhulme Centre for Demographic Science.
Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s
General Research
26 October 2021
A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.
Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis
General Research
26 October 2021
Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.
Oxford researchers awarded funding to complete community COVID-19 antiviral trial
Coronavirus COVID-19 General Research
26 October 2021
Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
New therapeutic targets identified to treat inflammatory bowel disease
General Research
22 October 2021
Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.
Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile
General Research
22 October 2021
A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.
Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age
General Research
21 October 2021
A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.
Drug could help diabetic hearts recover after heart attack - Oxford research
General Research
20 October 2021
Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.
Largest ever global study of tuberculosis identifies genetic causes of drug resistance
General Research
19 October 2021
Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.
Researchers set out steps to address mental health effects of the pandemic on young people
Coronavirus COVID-19 General Research
8 October 2021
Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.
Anti-cancer drug derived from fungus shows promise in clinical trials
Clinical Trials General Innovation Research
7 October 2021
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.
No benefit of convalescent plasma for critically ill COVID-19 patients
Coronavirus COVID-19 General Research
5 October 2021
A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.
Increased infectiousness of coronavirus variants explained
Coronavirus COVID-19 General Research
4 October 2021
Researchers from the Universities of Oxford and Dundee have made a discovery that helps explain why variations in the virus causes COVID-19 to spread so rapidly.
RECOVERY Trial paper wins BMJ’s 2021 UK Research Paper of the Year Award
Awards and Appointments Coronavirus COVID-19 General Research
30 September 2021
For the second year in a row, The British Medical Journal have selected a publication co-authored by Oxford University researchers for their prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare.
Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness
Awards and Appointments General Research
30 September 2021
Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.